Zyversa Therapeutics Incis A Clinical Stage Specialty Biopharmaceutical Company Dedicated To Developing Innovative Treatments For Inflammatory And Renal Diseasesthe Company Utilizes Advanced Proprietary Technologies To Create First In Class Drugs Aimed At Enhancing Health Outcomes And Quality Of Life For Patients Zyversa S Product Pipeline Includes Two Key Therapeutic Candidatesic 100 And Var 200Ic 100 Is A Monoclonal Antibody Designed To Inhibit The Adaptor Ascwhich Plays A Role In The Inflammatory Responsethis Product Aims To Treat Inflammatory Diseases By Modulating The Immune Systemvar 200 Functions As A Cholesterol Efflux Mediatortargeting Excess Cholesterol In The Kidney S Filtration System To Protect Against Structural Damage And Preserve Kidney Function In Patients With Chronic Kidney Diseaseszyversa Therapeutics Is Actively Engaged In Clinical Trialspositioning Itself As A Promising Entity In The Biopharmaceutical Industry Focused On Improving Treatment Options For Patients With Specific Health Challenges
No conferences found for this company.
| Company Name | Zyversa Therapeutics Inc |
| Country |
United States
|
| Address | N/A |
| Telephone | N/A |
| N/A |
